Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Tenaya Therapeutics, Inc. (TNYA)
USD0.84
-0.02 (-2.81%)
US NASDAQ Healthcare Biotechnology
Address
171 Oyster Point Boulevard 94080
South San Francisco, CA, US
South San Francisco, CA, US
CEO
Faraz Ali
Website
tenayatherapeutics.com
IPO
2021-07-30
CIK 1858848 ISIN US87990A1060
Description
Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in Phase 1b/2 clinical trial; and TN-301, a small molecule histone deacetylase-6 for heart failure with preserved ejection fraction that is in phase 1 clinical trial. The company develops its products through gene addition, gene editing, gene silencing, and cellular regeneration. It has a research collaboration agreement with Alnylam Pharmaceuticals, Inc. to identify and validate novel gene targets for the potential treatment of cardiovascular disease. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.84
-0.02 (-2.81%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
4M
Beta
2.82
Float Shares
156.21M
Free Float %
93.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +8.77% | +12.86% | +25.74% | +54.68% | -37.93% | +22.14% | +88.91% | -87.93% | -94.34% | -94.34% | -94.34% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (6 ratings, all time)
Buy
Price Targets & DCF
Current price
0.84
Low
2.00
+138.0%
Consensus
2.33
+177.3%
Median
2.00
+138.0%
High
3.00
+257.0%
DCF (Unlevered)
0.57
-32.6%
DCF (Levered)
0.59
-30.2%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 6 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
2.00
+138.0%
|
| Last Year | 3 |
2.33
+177.3%
|
| All Time | 3 |
2.33
+177.3%
|
Quality scores
Altman Z-Score
-5.09
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
B-
Overall Score
2 / 5
Medium
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+55.0% ★ Q1'26: +62.5% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%— Q1'26: -8,553.3% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%— Q1'26: -8,917.8% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-278.2% Q1'26: -226.6% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+80.3% Q1'26: +39.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.13× Q1'26: -0.14× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 7 EPS Ana. |
Dec 2027 2 Rev. Ana. 4 EPS Ana. |
Dec 2028 4 Rev. Ana. 4 EPS Ana. |
Dec 2029 3 Rev. Ana. 2 EPS Ana. |
Dec 2030 3 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
—
est: 833.3K (-100.0%)
|
—
est: 2.14M (-100.0%)
|
10.21M
10.06M – 10.29M
+376.5% YoY
|
103.74M
103.71M – 103.76M
+916.1% YoY
|
277.89M
277.81M – 277.93M
+167.9% YoY
|
1.36B
1.36B – 1.36B
+390.5% YoY
|
2.41B
2.41B – 2.41B
+76.6% YoY
|
| EBITDA |
-102.66M
|
-84.90M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-111.13M
|
-93.33M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-111.13M
est: -205.10M (+45.8%)
|
-90.60M
est: -83.01M (-9.1%)
|
-60.97M
-83.66M – -38.28M
+26.5% YoY
|
-60.72M
-81.42M – -40.02M
+0.4% YoY
|
120.53M
-61.86M – 250.94M
+298.5% YoY
|
452.03M
451.86M – 452.12M
+275.0% YoY
|
796.98M
796.69M – 797.14M
+76.3% YoY
|
| SGA |
20.74M
|
24.72M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-1.31
est: -1.35 (+3.0%)
|
-0.59
est: -0.60 (+2.3%)
|
-0.40
-0.55 – -0.25
+34.0% YoY
|
-0.41
-0.53 – -0.26
-4.1% YoY
|
0.18
-0.40 – 1.64
+142.9% YoY
|
2.96
2.95 – 2.96
+1,560.1% YoY
|
5.21
5.21 – 5.21
+76.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-27 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-26 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-22 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-21 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-20 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-19 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-18 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-15 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-14 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-13 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-12 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-11 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-08 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-07 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-05 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-04 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-01 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
108
Total invested
37.51M
Insider transactions (90d)
10
Beneficial owners (>5%)
19
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TCG Opportunity III GP, LLC | 9.62M | 15.00% | — | 9.62M | — | 9.62M | OO | — | 2022-12-01 | ↗ |
| 2 | The Column Group Opportunity III GP, LP | 9.62M | 15.00% | — | 9.62M | — | 9.62M | PN | — | 2022-12-01 | ↗ |
| 3 | The Column Group Opportunity III, LP | 9.62M | 15.00% | — | 9.62M | — | 9.62M | PN | — | 2022-12-01 | ↗ |
| 4 | The Column Group III GP, LP | 9.40M | 14.70% | — | 9.40M | — | 9.40M | PN | — | 2022-12-01 | ↗ |
| 5 | III-A, | 4.99M | 7.80% | — | 4.99M | — | 4.99M | PN | — | 2022-12-01 | ↗ |
| 6 | The Column Group III, LP | 4.41M | 6.90% | — | 4.41M | — | 4.41M | PN | — | 2022-12-01 | ↗ |
| 7 | (1) BlackRock, Inc. | 3.79M | 5.60% | 3.71M | — | 3.79M | — | HC | Delaware | 2024-01-31 | ↗ |
| 8 | Casdin Capital, LLC | 3.59M | 8.70% | — | 3.59M | — | 3.59M | IA | — | 2021-08-09 | ↗ |
| 9 | Eli Casdin | 3.59M | 8.70% | — | 3.59M | — | 3.59M | IN | — | 2021-08-09 | ↗ |
| 10 | Peter Kolchinsky | 3.55M | 8.60% | — | 3.55M | — | 3.55M | HC, IN | Delaware | 2021-08-09 | ↗ |
| 11 | Casdin Partners GP, LLC | 3.22M | 7.80% | — | 3.22M | — | 3.22M | OO | — | 2021-08-09 | ↗ |
| 12 | Casdin Partners Master Fund, L.P. | 3.22M | 7.80% | — | 3.22M | — | 3.22M | PN | — | 2021-08-09 | ↗ |
| 13 | Abigail P. Johnson | 3.13M | 7.56% | — | — | 3.13M | — | IN | Delaware | 2022-10-11 | ↗ |
| 14 | FMR LLC | 3.13M | 7.56% | 3.12M | — | 3.13M | — | HC | Delaware | 2022-10-11 | ↗ |
| 15 | 52-0556948 | 2.99M | 7.20% | 544.2K | — | 2.99M | — | IA | Maryland | 2022-02-14 | ↗ |
| 16 | Chidozie Ugwumba | 2.64M | 6.40% | 2.64M | — | 2.64M | — | IN | — | 2022-02-14 | ↗ |
| 17 | RTW Investments, LP | 2.46M | 6.00% | — | 2.46M | — | — | IA, PN | Delaware | 2022-02-14 | ↗ |
| 18 | Roderick Wong | 2.46M | 6.00% | — | 2.46M | — | — | HC, IN | United States | 2022-02-14 | ↗ |
| 19 | Thomas Layton Walton | — | 0.00% | — | — | — | — | IN | — | 2022-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
108
+4 vs prev Q
New positions
26
Closed positions
21
Increased
59
Reduced
18
Put/Call ratio
0.25
Calls held
275.7K
Puts held
68.7K
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | EMPERY ASSET MANAGEMENT, LP | 5.41M +5.4M (+100.0%) | 3.85B +3.9B (+100.0%) | 3.31% +3.315 pp | 3.40% +3.397 pp | USD0.71 +0.0% | 1 qtrs NEW |
| 2 | — | 2.00M +2.0M (+100.0%) | 1.42B +1.4B (+100.0%) | 1.22% +1.224 pp | 1.41% +1.408 pp | USD0.71 +0.0% | 1 qtrs NEW |
| 3 | COLUMN GROUP LLC | 9.40M +— (+0.0%) | 6.69M -8.2M (-54.9%) | 5.75% -0.020 pp | 8.08% -10.262 pp | USD20.65 -96.6% | 18 qtrs — |
| 4 | VANGUARD GROUP INC | 8.56M +3.5M (+69.0%) | 6.09M -2.1M (-25.7%) | 5.24% +2.129 pp | 0.00% +0.000 pp | USD3.30 -78.5% | 18 qtrs — |
| 5 | MILLENNIUM MANAGEMENT LLC | 4.62M +111.2K (+2.5%) | 3.28M -4.0M (-55.0%) | 2.83% +0.059 pp | 0.00% -0.002 pp | USD1.47 -51.7% | 15 qtrs — |
| 6 | ANSON FUNDS MANAGEMENT LP | 4.15M +4.2M (+100.0%) | 2.95M +3.0M (+100.0%) | 2.54% +2.542 pp | 0.28% +0.278 pp | USD0.71 +0.0% | 1 qtrs NEW |
| 7 | ALYESKA INVESTMENT GROUP, L.P. | 4.00M +4.0M (+100.0%) | 2.85M +2.8M (+100.0%) | 2.45% +2.449 pp | 0.01% +0.008 pp | USD0.71 +0.0% | 1 qtrs NEW |
| 8 | BLACKROCK, INC. | 3.95M +1.6M (+69.7%) | 2.81M -960.6K (-25.5%) | 2.42% +0.988 pp | 0.00% +0.000 pp | USD1.36 -47.8% | 6 qtrs — |
| 9 | BURKEHILL GLOBAL MANAGEMENT, LP | 2.00M +2.0M (+100.0%) | 1.42M +1.4M (+100.0%) | 1.22% +1.224 pp | 0.09% +0.094 pp | USD0.71 +0.0% | 1 qtrs NEW |
| 10 | RENAISSANCE TECHNOLOGIES LLC | 1.85M +172.7K (+10.3%) | 1.32M -1.4M (-51.6%) | 1.13% +0.102 pp | 0.00% -0.002 pp | USD0.59 +20.3% | 14 qtrs — |
| 11 | ADAR1 CAPITAL MANAGEMENT, LLC | 1.51M +1.5M (+100.0%) | 1.07M +1.1M (+100.0%) | 0.92% +0.922 pp | 0.08% +0.079 pp | USD0.71 +0.0% | 1 qtrs NEW |
| 12 | SPHERA FUNDS MANAGEMENT LTD. | 1.50M +1.5M (+100.0%) | 1.07M +1.1M (+100.0%) | 0.92% +0.918 pp | 0.21% +0.206 pp | USD0.71 +0.0% | 1 qtrs NEW |
| 13 | GSA CAPITAL PARTNERS LLP | 1.48M +1.0M (+220.2%) | 1.05M +304.0K (+40.6%) | 0.91% +0.622 pp | 0.09% +0.028 pp | USD1.00 -29.0% | 2 qtrs — |
| 14 | MARSHALL WACE, LLP | 1.41M +1.4M (+8,034.4%) | 998.3K +970.3K (+3,465.2%) | 0.86% +0.850 pp | 0.00% +0.001 pp | USD0.71 +0.0% | 3 qtrs — |
| 15 | TWO SIGMA INVESTMENTS, LP | 1.27M +355.5K (+39.0%) | 900.8K -574.3K (-38.9%) | 0.78% +0.216 pp | 0.00% -0.001 pp | USD1.10 -35.5% | 14 qtrs — |
| 16 | GEODE CAPITAL MANAGEMENT, LLC | 1.19M +17.8K (+1.5%) | 849.4K -1.1M (-55.4%) | 0.73% +0.009 pp | 0.00% 0.000 pp | USD6.63 -89.3% | 18 qtrs — |
| 17 | EUCLIDEAN CAPITAL LLC | 1.02M +— (+0.0%) | 722.7K -922.8K (-56.1%) | 0.62% -0.002 pp | 0.20% -0.496 pp | USD18.87 -96.2% | 18 qtrs — |
| 18 | ALPHABET INC. | 915.7K +— (+0.0%) | 650.2K -833.3K (-56.2%) | 0.56% -0.002 pp | 0.03% -0.036 pp | USD20.65 -96.6% | 18 qtrs — |
| 19 | RAIFFEISEN BANK INTERNATIONAL AG | 900.0K +550.0K (+157.1%) | 630.0K +77.0K (+13.9%) | 0.55% +0.336 pp | 0.01% +0.001 pp | USD1.06 -33.0% | 2 qtrs — |
| 20 | MIRADOR CAPITAL PARTNERS LP | 582.5K +559.0K (+2,378.8%) | 414.5K +376.4K (+988.7%) | 0.36% +0.342 pp | 0.06% +0.051 pp | USD0.72 -1.4% | 4 qtrs — |
| 21 | UBS GROUP AG | 579.6K +382.9K (+194.6%) | 412.7K +94.0K (+29.5%) | 0.35% +0.234 pp | 0.00% +0.000 pp | USD1.00 -29.0% | 18 qtrs — |
| 22 | STEPSTONE GROUP LP | 462.2K +— (+0.0%) | 328.1K -420.6K (-56.2%) | 0.28% -0.001 pp | 0.18% -0.176 pp | USD20.65 -96.6% | 18 qtrs — |
| 23 | STATE STREET CORP | 445.8K +— (+0.0%) | 317.2K -405.0K (-56.1%) | 0.27% -0.001 pp | 0.00% +0.000 pp | USD4.60 -84.6% | 18 qtrs — |
| 24 | TWO SIGMA ADVISERS, LP | 394.5K +181.0K (+84.8%) | 280.7K -65.2K (-18.8%) | 0.24% +0.110 pp | 0.00% 0.000 pp | USD0.77 -7.8% | 12 qtrs — |
| 25 | CASDIN CAPITAL, LLC | 362.0K +— (+0.0%) | 257.5K -328.8K (-56.1%) | 0.22% -0.001 pp | 0.02% -0.033 pp | USD12.27 -94.2% | 18 qtrs — |
| 26 | STONEPINE CAPITAL MANAGEMENT, LLC | 352.0K +352.0K (+100.0%) | 250.4K +250.4K (+100.0%) | 0.22% +0.216 pp | 0.18% +0.183 pp | USD0.71 +0.0% | 1 qtrs NEW |
| 27 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 284.6K -70.2K (-19.8%) | 202.5K -372.2K (-64.8%) | 0.17% -0.044 pp | 0.00% +0.000 pp | USD1.08 -34.3% | 13 qtrs — |
| 28 | NORTHERN TRUST CORP | 241.6K +2.1K (+0.9%) | 171.9K -216.1K (-55.7%) | 0.15% +0.001 pp | 0.00% +0.000 pp | USD5.51 -87.1% | 18 qtrs — |
| 29 | OMERS ADMINISTRATION CORP | 236.4K +236.4K (+100.0%) | 168.2K +168.2K (+100.0%) | 0.14% +0.145 pp | 0.00% +0.001 pp | USD0.71 +0.0% | 1 qtrs NEW |
| 30 | MORGAN STANLEY | 208.4K +41.3K (+24.7%) | 148.3K -122.4K (-45.2%) | 0.13% +0.025 pp | 0.00% +0.000 pp | USD1.55 -54.2% | 18 qtrs — |
| 31 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 194.8K +175.0K (+883.8%) | 138.6K +106.5K (+332.1%) | 0.12% +0.107 pp | 0.00% +0.002 pp | USD0.87 -18.4% | 13 qtrs — |
| 32 | MAREX GROUP PLC | 185.0K -117.5K (-38.8%) | 131.6K -358.4K (-73.1%) | 0.11% -0.073 pp | 0.00% -0.003 pp | USD0.61 +16.4% | 3 qtrs — |
| 33 | BARCLAYS PLC | 185.0K -84.5K (-31.3%) | 131.6K -388.4K (-74.7%) | 0.11% -0.052 pp | 0.00% 0.000 pp | USD1.72 -58.7% | 16 qtrs — |
| 34 | GRAHAM CAPITAL MANAGEMENT, L.P. | 178.8K +178.8K (+100.0%) | 127.2K +127.2K (+100.0%) | 0.11% +0.109 pp | 0.00% +0.003 pp | USD0.71 +0.0% | 1 qtrs NEW |
| 35 | JANE STREET GROUP, LLC | 128.1K +69.4K (+118.2%) | 91.1K -4.0K (-4.2%) | 0.08% +0.042 pp | 0.00% +0.000 pp | USD1.13 -37.2% | 2 qtrs — |
| 36 | CETERA INVESTMENT ADVISERS | 106.4K +55.0K (+107.0%) | 75.7K -7.6K (-9.1%) | 0.07% +0.034 pp | 0.00% +0.000 pp | USD1.15 -38.3% | 2 qtrs — |
| 37 | XTX TOPCO LTD | 105.7K +7.9K (+8.0%) | 75.2K -83.3K (-52.6%) | 0.06% +0.005 pp | 0.00% -0.006 pp | USD1.55 -54.2% | 2 qtrs — |
| 38 | CI PRIVATE WEALTH, LLC | 100.8K +100.8K (+100.0%) | 71.7K +71.7K (+100.0%) | 0.06% +0.062 pp | 0.00% +0.000 pp | USD0.71 +0.0% | 1 qtrs NEW |
| 39 | CITADEL ADVISORS LLC | 93.5K -9.9K (-9.6%) | 66.5K -101.0K (-60.3%) | 0.06% -0.006 pp | 0.00% +0.000 pp | USD1.35 -47.4% | 13 qtrs — |
| 40 | LIGHTHOUSE INVESTMENT PARTNERS, LLC | 87.6K +87.6K (+100.0%) | 62.3K +62.3K (+100.0%) | 0.05% +0.054 pp | 0.00% +0.002 pp | USD0.71 +0.0% | 1 qtrs NEW |
| 41 | JACOBS LEVY EQUITY MANAGEMENT, INC | 75.9K +75.9K (+100.0%) | 54.0K +54.0K (+100.0%) | 0.05% +0.047 pp | 0.00% +0.000 pp | USD0.71 +0.0% | 1 qtrs NEW |
| 42 | PATHSTONE HOLDINGS, LLC | 75.0K +— (+0.0%) | 53.4K -68.1K (-56.1%) | 0.05% 0.000 pp | 0.00% 0.000 pp | USD0.57 +24.6% | 4 qtrs — |
| 43 | DIMENSIONAL FUND ADVISORS LP | 70.5K -2.9K (-4.0%) | 50.1K -68.8K (-57.8%) | 0.04% -0.002 pp | 0.00% +0.000 pp | USD2.83 -74.9% | 12 qtrs — |
| 44 | GOLDMAN SACHS GROUP INC | 68.0K -159.5K (-70.1%) | 48.4K -320.2K (-86.9%) | 0.04% -0.098 pp | 0.00% +0.000 pp | USD2.72 -73.9% | 17 qtrs — |
| 45 | JEFFERIES FINANCIAL GROUP INC. | 58.2K -3.1K (-5.0%) | 41.4K -57.9K (-58.3%) | 0.04% -0.002 pp | 0.00% 0.000 pp | USD1.62 -56.2% | 2 qtrs — |
| 46 | CALLAN FAMILY OFFICE, LLC | 50.1K +13.8K (+38.0%) | 35.6K -23.1K (-39.4%) | 0.03% +0.008 pp | 0.00% -0.001 pp | USD0.61 +16.4% | 4 qtrs — |
| 47 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 50.0K +— (+0.0%) | 35.6K -45.4K (-56.1%) | 0.03% 0.000 pp | 0.00% +0.000 pp | USD1.62 -56.2% | 18 qtrs — |
| 48 | VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 46.0K +149.0 (+0.3%) | 32.7K -41.5K (-55.9%) | 0.03% +0.000 pp | 0.00% 0.000 pp | USD0.79 -10.1% | 5 qtrs — |
| 49 | ATTICUS WEALTH MANAGEMENT, LLC | 43.2K -1.6K (-3.6%) | 30.8K -41.9K (-57.7%) | 0.03% -0.001 pp | 0.01% -0.011 pp | USD4.27 -83.4% | 11 qtrs — |
| 50 | SIMPLEX TRADING, LLC | 38.5K -73.4K (-65.6%) | 27.4K -153.6K (-84.8%) | 0.02% -0.045 pp | 0.00% 0.000 pp | USD1.58 -55.1% | 14 qtrs — |
| 51 | POINT72 ASSET MANAGEMENT, L.P. | 38.5K +38.5K (+100.0%) | 27.4K +27.4K (+100.0%) | 0.02% +0.024 pp | 0.00% +0.000 pp | USD0.71 +0.0% | 1 qtrs NEW |
| 52 | ADVISOR GROUP HOLDINGS, INC. | 34.4K +400.0 (+1.2%) | 24.4K -29.3K (-54.5%) | 0.02% +0.000 pp | 0.00% +0.000 pp | USD1.41 -49.6% | 7 qtrs — |
| 53 | VIRTU FINANCIAL LLC | 32.7K -11.5K (-26.0%) | 23.0K -49.0K (-68.1%) | 0.02% -0.007 pp | 0.00% -0.003 pp | USD1.11 -36.0% | 7 qtrs — |
| 54 | PRICE T ROWE ASSOCIATES INC /MD/ | 31.5K +— (+0.0%) | 23.0K -28.0K (-54.9%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD9.52 -92.5% | 18 qtrs — |
| 55 | BANK OF AMERICA CORP /DE/ | 32.1K -9.9K (-23.6%) | 22.8K -45.2K (-66.5%) | 0.02% -0.006 pp | 0.00% +0.000 pp | USD3.75 -81.1% | 18 qtrs — |
| 56 | EWA, LLC | 31.4K +1.7K (+5.6%) | 22.4K -25.8K (-53.6%) | 0.02% +0.001 pp | 0.01% -0.008 pp | USD0.62 +14.5% | 3 qtrs — |
| 57 | AQR CAPITAL MANAGEMENT LLC | 28.7K -130.9K (-82.0%) | 20.5K -238.1K (-92.1%) | 0.02% -0.081 pp | 0.00% 0.000 pp | USD0.59 +20.3% | 4 qtrs — |
| 58 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 27.1K +27.1K (+100.0%) | 19.3K +19.3K (+100.0%) | 0.02% +0.017 pp | 0.00% +0.002 pp | USD0.71 +0.0% | 1 qtrs NEW |
| 59 | CITIGROUP INC | 23.5K +22.6K (+2,691.3%) | 16.7K +15.3K (+1,126.3%) | 0.01% +0.014 pp | 0.00% +0.000 pp | USD0.78 -9.0% | 18 qtrs — |
| 60 | MARINER, LLC | 22.1K +1.7K (+8.2%) | 15.7K -17.3K (-52.5%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD1.00 -29.0% | 5 qtrs — |
| 61 | KESTRA PRIVATE WEALTH SERVICES, LLC | 22.0K +— (+0.0%) | 15.7K -20.0K (-56.1%) | 0.01% +0.000 pp | 0.00% 0.000 pp | USD0.61 +16.4% | 3 qtrs — |
| 62 | INTEGRATED WEALTH CONCEPTS LLC | 21.9K -92.0 (-0.4%) | 15.6K -20.1K (-56.3%) | 0.01% 0.000 pp | 0.00% 0.000 pp | USD2.01 -64.7% | 13 qtrs — |
| 63 | PENSIONMARK FINANCIAL GROUP, LLC | 18.8K +5.0K (+36.3%) | 13.4K -9.0K (-40.2%) | 0.01% +0.003 pp | 0.00% 0.000 pp | USD0.64 +10.9% | 3 qtrs — |
| 64 | CITIZENS FINANCIAL GROUP INC/RI | 18.0K +18.0K (+100.0%) | 12.8K +12.8K (+100.0%) | 0.01% +0.011 pp | 0.00% +0.000 pp | USD0.71 +0.0% | 1 qtrs NEW |
| 65 | VICTORY CAPITAL MANAGEMENT INC | 17.6K +17.6K (+100.0%) | 12.6K +12.6K (+100.0%) | 0.01% +0.011 pp | 0.00% +0.000 pp | USD0.71 +0.0% | 1 qtrs NEW |
| 66 | PARKWOODS WEALTH PARTNERS, LLC | 17.0K +2.0K (+13.3%) | 12.1K -12.2K (-50.2%) | 0.01% +0.001 pp | 0.00% -0.005 pp | USD1.51 -53.0% | 2 qtrs — |
| 67 | PRUDENTIAL FINANCIAL INC | 16.2K +16.2K (+100.0%) | 11.5K +11.5K (+100.0%) | 0.01% +0.010 pp | 0.00% +0.000 pp | USD0.71 +0.0% | 1 qtrs NEW |
| 68 | COMMERCE BANK | 15.0K -10.0K (-40.0%) | 10.7K -29.8K (-73.6%) | 0.01% -0.006 pp | 0.00% 0.000 pp | USD1.14 -37.7% | 5 qtrs — |
| 69 | LPL FINANCIAL LLC | 14.8K -7.5K (-33.7%) | 10.5K -25.7K (-70.9%) | 0.01% -0.005 pp | 0.00% +0.000 pp | USD1.62 -56.2% | 4 qtrs — |
| 70 | FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 14.5K +— (+0.0%) | 10.3K -13.2K (-56.0%) | 0.01% +0.000 pp | 0.00% 0.000 pp | USD1.37 -48.2% | 6 qtrs — |
| 71 | JPMORGAN CHASE & CO | 13.8K +13.3K (+2,564.2%) | 9.8K +9.0K (+1,069.8%) | 0.01% +0.008 pp | 0.00% +0.000 pp | USD0.75 -5.3% | 18 qtrs — |
| 72 | BNP PARIBAS ARBITRAGE, SNC | 12.3K +11.5K (+1,369.5%) | 8.8K +7.4K (+545.3%) | 0.01% +0.007 pp | 0.00% +0.000 pp | USD0.76 -6.6% | 5 qtrs — |
| 73 | APTUS CAPITAL ADVISORS, LLC | 12.1K +— (+0.0%) | 8.6K -11.0K (-56.1%) | 0.01% +0.000 pp | 0.00% 0.000 pp | USD1.62 -56.2% | 2 qtrs — |
| 74 | GALVIN, GAUSTAD & STEIN, LLC | 11.0K +— (+0.0%) | 7.8K -10.0K (-56.1%) | 0.01% +0.000 pp | 0.00% -0.001 pp | USD0.61 +16.4% | 3 qtrs — |
| 75 | SEQUOIA FINANCIAL ADVISORS, LLC | 10.7K +10.7K (+100.0%) | 7.6K +7.6K (+100.0%) | 0.01% +0.007 pp | 0.00% +0.000 pp | USD0.71 +0.0% | 1 qtrs NEW |
| 76 | JASPER RIDGE PARTNERS, L.P. | 10.3K +— (+0.0%) | 7.3K -9.3K (-56.1%) | 0.01% +0.000 pp | 0.00% 0.000 pp | USD15.20 -95.3% | 18 qtrs — |
| 77 | QUADCAP WEALTH MANAGEMENT, LLC | 10.0K +10.0K (+100.0%) | 7.1K +7.1K (+100.0%) | 0.01% +0.006 pp | 0.00% +0.001 pp | USD0.71 +0.0% | 1 qtrs NEW |
| 78 | X-SQUARE CAPITAL, LLC | 10.0K +— (+0.0%) | 7.0K -9.0K (-56.3%) | 0.01% +0.000 pp | 0.00% -0.003 pp | USD0.61 +16.4% | 3 qtrs — |
| 79 | GROUP ONE TRADING, L.P. | 9.5K -23.2K (-70.9%) | 6.8K -46.2K (-87.2%) | 0.01% -0.014 pp | 0.00% 0.000 pp | USD1.50 -52.7% | 5 qtrs — |
| 80 | MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 8.1K +8.1K (+100.0%) | 5.8K +5.8K (+100.0%) | 0.01% +0.005 pp | 0.00% +0.000 pp | USD0.71 +0.0% | 1 qtrs NEW |
| 81 | VSM WEALTH ADVISORY, LLC | 5.0K +5.0K (+100.0%) | 3.6K +3.6K (+100.0%) | 0.00% +0.003 pp | 0.00% +0.001 pp | USD0.71 +0.0% | 1 qtrs NEW |
| 82 | ROYAL BANK OF CANADA | 3.7K -260.7K (-98.6%) | 3.0K -425.0K (-99.3%) | 0.00% -0.160 pp | 0.00% 0.000 pp | USD0.63 +12.7% | 18 qtrs — |
| 83 | WELLS FARGO & COMPANY/MN | 4.0K +3.0K (+300.0%) | 2.8K +1.2K (+75.7%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD1.17 -39.3% | 12 qtrs — |
| 84 | FMR LLC | 2.8K +— (+0.0%) | 2.0K -2.5K (-56.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD14.44 -95.1% | 18 qtrs — |
| 85 | TFC FINANCIAL MANAGEMENT, INC. | 2.5K +— (+0.0%) | 1.8K -2.3K (-56.1%) | 0.00% +0.000 pp | 0.00% 0.000 pp | USD1.62 -56.2% | 2 qtrs — |
| 86 | NISA INVESTMENT ADVISORS, LLC | 2.3K +— (+0.0%) | 1.6K -2.0K (-56.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.72 -1.4% | 14 qtrs — |
| 87 | EVERSOURCE WEALTH ADVISORS, LLC | 1.5K -1.1K (-41.4%) | 1.1K -3.2K (-74.3%) | 0.00% -0.001 pp | 0.00% 0.000 pp | USD0.60 +18.3% | 4 qtrs — |
| 88 | CWM, LLC | 1.6K -13.1K (-89.4%) | 1.0K -23.0K (-95.8%) | 0.00% -0.008 pp | 0.00% 0.000 pp | USD0.58 +22.4% | 5 qtrs — |
| 89 | FARTHER FINANCE ADVISORS, LLC | 1.0K +— (+0.0%) | 712.00 -908.0 (-56.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.61 +16.4% | 3 qtrs — |
| 90 | SBI SECURITIES CO., LTD. | 783.00 -701.0 (-47.2%) | 557.00 -1.8K (-76.8%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD1.43 -50.3% | 5 qtrs — |
| 91 | CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 588.00 +588.0 (+100.0%) | 418.00 +418.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.71 +0.0% | 4 qtrs — |
| 92 | JONES FINANCIAL COMPANIES LLLP | 100.00 +100.0 (+100.0%) | 71.00 +71.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.71 +0.0% | 1 qtrs NEW |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 20 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Invesco NASDAQ Future Gen 200 ETF QQQS | 0.50% | 109.9K | 0.20% |
| 2 | iShares Biotechnology ETF IBB | 0.01% | 1.32M | 0.44% |
| 3 | iShares Nasdaq US Biotechnology UCITS ETF BTEC.L | 0.01% | 151.4K | 0.35% |
| 4 | iShares Nasdaq US Biotechnology UCITS ETF BTEE.L | 0.01% | 10.1K | 0.35% |
| 5 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.01% | 59.9K | 0.40% |
| 6 | Invesco Nasdaq Biotechnology ETF IBBQ | 0.01% | 9.7K | 0.19% |
| 7 | ProShares Ultra Nasdaq Biotechnology BIB | 0.01% | 6.3K | 1.19% |
| 8 | Invesco RAFI US 1500 Small-Mid ETF PRFZ | 0.01% | 192.9K | 0.34% |
| 9 | Vanguard Extended Market ETF VXF | 0.00% | 1.50M | 0.05% |
| 10 | Avantis Total Equity Markets ETF 1 AVTM | 0.00% | 3.2K | 0.23% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
2.33
Bullish
Ratio by volume
3.00
Bullish
Buys
7
Sells
3
Shares acquired
840.0K
Shares disposed
8.0K
Cash buys
—
Cash sales
3.00
Net activity
+832,004
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | Williams R Sanders | Director | A-Award | A | Stock Option (Right to buy) | 120,000 | 0.80 | 95.9K | 120,000 | D | ↗ |
| 2026-05-28 | Walsh Jeffrey T. | Director | A-Award | A | Stock Option (Right to buy) | 120,000 | 0.80 | 95.9K | 120,000 | D | ↗ |
| 2026-05-28 | Stehman-Breen Catherine | Director | A-Award | A | Stock Option (Right to buy) | 120,000 | 0.80 | 95.9K | 120,000 | D | ↗ |
| 2026-05-28 | Srivastava Deepak | Director | A-Award | A | Stock Option (Right to buy) | 120,000 | 0.80 | 95.9K | 120,000 | D | ↗ |
| 2026-05-28 | Parschauer Karah Herdman | Director | A-Award | A | Stock Option (Right to buy) | 120,000 | 0.80 | 95.9K | 120,000 | D | ↗ |
| 2026-05-28 | Lee June | Director | A-Award | A | Stock Option (Right to buy) | 120,000 | 0.80 | 95.9K | 120,000 | D | ↗ |
| 2026-05-28 | Burroughs Amy L. | Director | A-Award | A | Stock Option (Right to buy) | 120,000 | 0.80 | 95.9K | 120,000 | D | ↗ |
| 2026-05-18 | Tingley Whittemore | Officer | S-Sale | D | Common Stock | 3,121 | 0.79 | 2.5K | 215,497 | D | ↗ |
| 2026-05-18 | Higa Tomohiro | Officer | S-Sale | D | Common Stock | 1,485 | 0.79 | 1.2K | 118,267 | D | ↗ |
| 2026-05-18 | Ali Faraz | Director / Officer | S-Sale | D | Common Stock | 3,390 | 0.79 | 2.7K | 440,014 | D | ↗ |
| 2026-02-25 | COLUMN GROUP III GP, LP | 10% Owner | S-Sale | D | Common Stock | 1,862,545 | 0.56 | 1.05M | 0 | I | ↗ |
| 2026-02-24 | COLUMN GROUP III GP, LP | 10% Owner | S-Sale | D | Common Stock | 349,212 | 0.62 | 214.9K | 1,862,545 | I | ↗ |
| 2026-02-23 | COLUMN GROUP III GP, LP | 10% Owner | S-Sale | D | Common Stock | 162,291 | 0.60 | 96.9K | 2,211,757 | I | ↗ |
| 2026-02-20 | COLUMN GROUP III GP, LP | 10% Owner | S-Sale | D | Common Stock | 245,965 | 0.61 | 151.2K | 2,102,218 | I | ↗ |
| 2026-02-17 | Tingley Whittemore | Officer | S-Sale | D | Common Stock | 1,642 | 0.64 | 1.1K | 222,136 | D | ↗ |
| 2026-02-17 | Higa Tomohiro | Officer | S-Sale | D | Common Stock | 611 | 0.64 | 393.12 | 122,610 | D | ↗ |
| 2026-02-17 | Ali Faraz | Director / Officer | S-Sale | D | Common Stock | 5,851 | 0.64 | 3.8K | 452,415 | D | ↗ |
| 2026-02-11 | COLUMN GROUP III GP, LP | 10% Owner | S-Sale | D | Common Stock | 2,151,458 | 0.68 | 1.46M | 2,651,817 | I | ↗ |
| 2026-02-10 | COLUMN GROUP III GP, LP | 10% Owner | S-Sale | D | Common Stock | 182,295 | 0.82 | 148.8K | 4,803,275 | I | ↗ |
| 2026-02-03 | Tingley Whittemore | Officer | A-Award | A | Common Stock | 48,750 | 0.00 | — | 223,778 | D | ↗ |
| 2026-02-03 | Higa Tomohiro | Officer | A-Award | A | Stock Option (Right to buy) | 175,500 | 0.92 | 160.6K | 175,500 | D | ↗ |
| 2026-02-03 | Ali Faraz | Director / Officer | A-Award | A | Common Stock | 158,600 | 0.00 | — | 458,266 | D | ↗ |
| 2025-11-17 | Tingley Whittemore | Officer | S-Sale | D | Common Stock | 2,877 | 1.33 | 3.8K | 169,926 | D | ↗ |
| 2025-11-17 | Higa Tomohiro | Officer | S-Sale | D | Common Stock | 1,367 | 1.33 | 1.8K | 93,971 | D | ↗ |
| 2025-11-17 | Ali Faraz | Director / Officer | S-Sale | D | Common Stock | 3,126 | 1.33 | 4.2K | 299,666 | D | ↗ |
| 2025-08-18 | Tingley Whittemore | Officer | S-Sale | D | Common Stock | 1,608 | 1.25 | 2.0K | 174,640 | D | ↗ |
| 2025-08-18 | Higa Tomohiro | Officer | S-Sale | D | Common Stock | 717 | 1.25 | 898.40 | 97,060 | D | ↗ |
| 2025-08-18 | Ali Faraz | Director / Officer | S-Sale | D | Common Stock | 3,893 | 1.25 | 4.9K | 307,712 | D | ↗ |
| 2025-05-29 | Williams R Sanders | Director | A-Award | A | Stock Option (Right to buy) | 107,400 | 0.44 | 47.7K | 107,400 | D | ↗ |
| 2025-05-29 | Walsh Jeffrey T. | Director | A-Award | A | Stock Option (Right to buy) | 107,400 | 0.44 | 47.7K | 107,400 | D | ↗ |
| 2025-05-29 | Stehman-Breen Catherine | Director | A-Award | A | Stock Option (Right to buy) | 107,400 | 0.44 | 47.7K | 107,400 | D | ↗ |
| 2025-05-29 | Srivastava Deepak | Director | A-Award | A | Stock Option (Right to buy) | 107,400 | 0.44 | 47.7K | 107,400 | D | ↗ |
| 2025-05-29 | Parschauer Karah Herdman | Director | A-Award | A | Stock Option (Right to buy) | 107,400 | 0.44 | 47.7K | 107,400 | D | ↗ |
| 2025-05-29 | Lee June | Director | A-Award | A | Stock Option (Right to buy) | 107,400 | 0.44 | 47.7K | 107,400 | D | ↗ |
| 2025-05-29 | GOEDDEL DAVID V | Director / 10% Owner | A-Award | A | Stock Option (Right to buy) | 107,400 | 0.44 | 47.7K | 107,400 | D | ↗ |
| 2025-05-29 | Burroughs Amy L. | Director | A-Award | A | Stock Option (Right to buy) | 107,400 | 0.44 | 47.7K | 107,400 | D | ↗ |
| 2025-05-16 | Tingley Whittemore | Officer | S-Sale | D | Common Stock | 2,937 | 0.44 | 1.3K | 171,856 | D | ↗ |
| 2025-05-16 | Higa Tomohiro | Officer | S-Sale | D | Common Stock | 1,390 | 0.44 | 615.35 | 98,300 | D | ↗ |
| 2025-05-16 | Ali Faraz | Director / Officer | S-Sale | D | Common Stock | 3,189 | 0.44 | 1.4K | 317,325 | D | ↗ |
| 2025-03-10 | Tingley Whittemore | Officer | S-Sale | D | Common Stock | 4,073 | 0.54 | 2.2K | 176,391 | D | ↗ |
| 2025-03-10 | Higa Tomohiro | Officer | S-Sale | D | Common Stock | 620 | 0.54 | 333.81 | 100,535 | D | ↗ |
| 2025-03-10 | Ali Faraz | Director / Officer | S-Sale | D | Common Stock | 3,947 | 0.54 | 2.1K | 320,514 | D | ↗ |
| 2025-03-05 | GOEDDEL DAVID V | Director / 10% Owner | P-Purchase | A | Common Stock | 35,714,284 | 0.70 | 25.00M | 49,313,559 | I | ↗ |
| 2025-03-05 | COLUMN GROUP III GP, LP | 10% Owner | P-Purchase | A | Common Stock | 35,714,284 | 0.70 | 25.00M | 49,313,559 | I | ↗ |
| 2025-02-24 | Higa Tomohiro | Officer | — | — | Stock Option (Right to Buy) | 50,000 | 1.21 | 60.5K | 0 | D | ↗ |
| 2025-02-06 | Higa Tomohiro | Officer | — | — | Common Stock | 0 | 0.00 | — | 30,484 | D | ↗ |
| 2025-02-06 | Ali Faraz | Director / Officer | A-Award | A | Stock Option (Right to buy) | 650,000 | 1.00 | 650.0K | 650,000 | D | ↗ |
| 2025-01-24 | Tingley Whittemore | Officer | D-Return | D | Stock Option (Right to Buy) | 215,000 | 5.22 | 1.12M | 0 | D | ↗ |
| 2024-11-18 | Saito Chihiro | Officer | S-Sale | D | Common Stock | 2,258 | 2.12 | 4.8K | 60,983 | D | ↗ |
| 2024-10-18 | Williams R Sanders | Director | A-Award | A | Stock Option (Right to buy) | 34,000 | 2.04 | 69.4K | 34,000 | D | ↗ |
| 2024-10-18 | Walsh Jeffrey T. | Director | A-Award | A | Stock Option (Right to buy) | 34,000 | 2.04 | 69.4K | 34,000 | D | ↗ |
| 2024-10-18 | Stehman-Breen Catherine | Director | A-Award | A | Stock Option (Right to buy) | 34,000 | 2.04 | 69.4K | 34,000 | D | ↗ |
| 2024-10-18 | Srivastava Deepak | Director | A-Award | A | Stock Option (Right to buy) | 34,000 | 2.04 | 69.4K | 34,000 | D | ↗ |
| 2024-10-18 | Parschauer Karah Herdman | Director | A-Award | A | Stock Option (Right to buy) | 34,000 | 2.04 | 69.4K | 34,000 | D | ↗ |
| 2024-10-18 | Lee June | Director | A-Award | A | Stock Option (Right to buy) | 34,000 | 2.04 | 69.4K | 34,000 | D | ↗ |
| 2024-10-18 | GOEDDEL DAVID V | Director / 10% Owner | A-Award | A | Stock Option (Right to buy) | 34,000 | 2.04 | 69.4K | 34,000 | D | ↗ |
| 2024-10-18 | Burroughs Amy L. | Director | A-Award | A | Stock Option (Right to buy) | 34,000 | 2.04 | 69.4K | 34,000 | D | ↗ |
| 2024-08-16 | Tingley Whittemore | Officer | S-Sale | D | Common Stock | 5,803 | 2.89 | 16.8K | 108,731 | — | ↗ |
| 2024-08-16 | Saito Chihiro | Officer | S-Sale | D | Common Stock | 902 | 2.89 | 2.6K | 64,702 | — | ↗ |
| 2024-08-16 | Ali Faraz | Director / Officer | S-Sale | D | Common Stock | 3,946 | 2.89 | 11.4K | 188,331 | — | ↗ |
| 2024-08-15 | Saito Chihiro | Officer | A-Award | A | Common Stock | 25,000 | 0.00 | — | 65,604 | — | ↗ |
| 2024-08-14 | Saito Chihiro | Officer | — | D | Common Stock | 0 | 0.00 | — | 7,832 | — | ↗ |
| 2024-03-23 | Saito Chihiro | Officer | — | D | Stock Option (Right to Buy) | 32,750 | 5.22 | 171.0K | 0 | — | ↗ |
| 2024-03-05 | Hoey Timothy | Officer | S-Sale | D | Common Stock | 3,300 | 7.00 | 23.1K | 245,346 | — | ↗ |
| 2024-02-23 | Tingley Whittemore | Officer | A-Award | A | Common Stock | 35,000 | 0.00 | — | 108,534 | — | ↗ |
| 2024-02-23 | PATTERSON LEONE D | Officer | A-Award | A | Common Stock | 35,000 | 0.00 | — | 95,755 | — | ↗ |
| 2024-02-23 | Hoey Timothy | Officer | A-Award | A | Stock Option (Right to buy) | 75,000 | 5.22 | 391.5K | 75,000 | — | ↗ |
| 2024-02-23 | Ali Faraz | Director / Officer | A-Award | A | Stock Option (Right to buy) | 505,000 | 5.22 | 2.64M | 505,000 | — | ↗ |
| 2024-02-20 | Hoey Timothy | Officer | S-Sale | D | Common Stock | 6,369 | 5.31 | 33.8K | 236,346 | — | ↗ |
| 2024-02-16 | Tingley Whittemore | Officer | S-Sale | D | Common Stock | 6,500 | 5.86 | 38.1K | 73,534 | — | ↗ |
| 2024-02-16 | PATTERSON LEONE D | Officer | S-Sale | D | Common Stock | 5,201 | 5.86 | 30.5K | 60,755 | — | ↗ |
| 2024-02-16 | Hoey Timothy | Officer | S-Sale | D | Common Stock | 4,681 | 5.86 | 27.4K | 242,715 | — | ↗ |
| 2024-02-16 | Ali Faraz | Director / Officer | S-Sale | D | Common Stock | 6,358 | 5.86 | 37.3K | 113,079 | — | ↗ |
| 2024-02-12 | GOEDDEL DAVID V | Director / 10% Owner | P-Purchase | A | Common Stock | 2,222,222 | 4.50 | 10.00M | 13,599,275 | — | ↗ |
| 2024-02-12 | COLUMN GROUP III GP, LP | 10% Owner | P-Purchase | A | Common Stock | 2,222,222 | 4.50 | 10.00M | 13,599,275 | — | ↗ |
| 2023-08-29 | Hoey Timothy | Officer | S-Sale | D | Common Stock | 7,243 | 4.26 | 30.9K | 247,396 | — | ↗ |
| 2023-08-16 | Tingley Whittemore | Officer | S-Sale | D | Common Stock | 5,563 | 3.81 | 21.2K | 76,437 | — | ↗ |
| 2023-08-16 | PATTERSON LEONE D | Officer | S-Sale | D | Common Stock | 4,452 | 3.81 | 17.0K | 64,542 | — | ↗ |
| 2023-08-16 | Hoey Timothy | Officer | S-Sale | D | Common Stock | 4,007 | 3.81 | 15.3K | 254,639 | — | ↗ |
| 2023-08-16 | Ali Faraz | Director / Officer | S-Sale | D | Common Stock | 5,563 | 3.81 | 21.2K | 119,437 | — | ↗ |
| 2023-06-09 | Williams R Sanders | Director | A-Award | A | Stock Option (Right to buy) | 29,532 | 7.12 | 210.3K | 29,532 | — | ↗ |
| 2023-06-09 | Walsh Jeffrey T. | Director | A-Award | A | Stock Option (Right to buy) | 29,532 | 7.12 | 210.3K | 29,532 | — | ↗ |
| 2023-06-09 | Stehman-Breen Catherine | Director | A-Award | A | Stock Option (Right to buy) | 29,532 | 7.12 | 210.3K | 29,532 | — | ↗ |
| 2023-06-09 | Srivastava Deepak | Director | A-Award | A | Stock Option (Right to buy) | 29,532 | 7.12 | 210.3K | 29,532 | — | ↗ |
| 2023-06-09 | Parschauer Karah Herdman | Director | A-Award | A | Stock Option (Right to buy) | 29,532 | 7.12 | 210.3K | 29,532 | — | ↗ |
| 2023-06-09 | Lee June | Director | A-Award | A | Stock Option (Right to buy) | 29,532 | 7.12 | 210.3K | 29,532 | — | ↗ |
| 2023-06-09 | GOEDDEL DAVID V | Director / 10% Owner | A-Award | A | Stock Option (Right to buy) | 29,532 | 7.12 | 210.3K | 29,532 | — | ↗ |
| 2023-06-09 | CHEN JIN-LONG | Director | A-Award | A | Stock Option (Right to buy) | 29,532 | 7.12 | 210.3K | 29,532 | — | ↗ |
| 2023-06-09 | Burroughs Amy L. | Director | A-Award | A | Stock Option (Right to buy) | 14,766 | 7.12 | 105.1K | 14,766 | — | ↗ |
| 2023-03-15 | Saito Chihiro | Officer | — | D | Stock Option (Right to Buy) | 28,125 | 3.06 | 86.1K | 0 | — | ↗ |
| 2023-03-10 | GOEDDEL DAVID V | Director / 10% Owner | P-Purchase | A | Common Stock | 6,779 | 2.60 | 17.6K | 11,377,053 | — | ↗ |
| 2023-03-10 | COLUMN GROUP III GP, LP | 10% Owner | P-Purchase | A | Common Stock | 6,779 | 2.60 | 17.6K | 11,377,053 | — | ↗ |
| 2023-02-15 | Tingley Whittemore | Officer | A-Award | A | Common Stock | 35,000 | 0.00 | — | 35,000 | — | ↗ |
| 2023-02-15 | PATTERSON LEONE D | Officer | A-Award | A | Common Stock | 30,000 | 0.00 | — | 32,000 | — | ↗ |
| 2023-02-15 | Hoey Timothy | Officer | A-Award | A | Stock Option (Right to buy) | 175,000 | 3.06 | 535.5K | 175,000 | — | ↗ |
| 2023-02-15 | Ali Faraz | Director / Officer | A-Award | A | Common Stock | 125,000 | 0.00 | — | 125,000 | — | ↗ |
| 2023-02-08 | GOEDDEL DAVID V | Director / 10% Owner | P-Purchase | A | Common Stock | 1,500,000 | 2.60 | 3.90M | 11,370,274 | — | ↗ |
| 2023-02-08 | COLUMN GROUP III GP, LP | 10% Owner | P-Purchase | A | Common Stock | 1,500,000 | 2.60 | 3.90M | 11,370,274 | — | ↗ |
| 2023-01-19 | GOEDDEL DAVID V | Director | P-Purchase | A | Common Stock | 69,739 | 2.50 | 174.2K | 9,870,274 | — | ↗ |
| 2023-01-19 | COLUMN GROUP III GP, LP | Director | P-Purchase | A | Common Stock | 69,739 | 2.50 | 174.2K | 9,870,274 | — | ↗ |
| 2023-01-18 | GOEDDEL DAVID V | Director | P-Purchase | A | Common Stock | 135,688 | 2.52 | 341.4K | 9,800,535 | — | ↗ |
| 2023-01-18 | COLUMN GROUP III GP, LP | Director | P-Purchase | A | Common Stock | 135,688 | 2.52 | 341.4K | 9,800,535 | — | ↗ |
| 2023-01-17 | GOEDDEL DAVID V | Director | P-Purchase | A | Common Stock | 49,463 | 2.49 | 123.4K | 9,664,847 | — | ↗ |
| 2023-01-17 | COLUMN GROUP III GP, LP | Director | P-Purchase | A | Common Stock | 49,463 | 2.49 | 123.4K | 9,664,847 | — | ↗ |
| 2022-12-05 | Burroughs Amy L. | — | — | — | — | — | — | — | 0 | — | ↗ |
| 2022-11-21 | Srivastava Deepak | Director | P-Purchase | A | Common Stock | 230,769 | 2.60 | 600.0K | 372,435 | — | ↗ |
| 2022-11-21 | GOEDDEL DAVID V | Director | P-Purchase | A | Common Stock | 9,615,384 | 2.60 | 25.00M | 9,615,384 | — | ↗ |
| 2022-11-21 | COLUMN GROUP III GP, LP | Director | P-Purchase | A | Common Stock | 9,615,384 | 2.60 | 25.00M | 9,615,384 | — | ↗ |
| 2022-11-17 | Casdin Eli | Director | P-Purchase | A | Common Stock | 2,492,042 | 2.60 | 6.48M | 6,078,860 | — | ↗ |
| 2022-09-30 | Saito Chihiro | Officer | — | D | Stock Option (Right to Buy) | 49,000 | 20.65 | 1.01M | 0 | — | ↗ |
| 2022-09-08 | Parschauer Karah Herdman | Director | A-Award | A | Stock Option (Right to buy) | 20,000 | 0.00 | — | 20,000 | — | ↗ |
| 2022-06-13 | CHEN JIN-LONG | Director | A-Award | A | Stock Option (Right to buy) | 39,727 | 0.00 | — | 39,727 | — | ↗ |
| 2022-06-10 | Williams R Sanders | Director | A-Award | A | Stock Option (Right to buy) | 39,727 | 5.26 | 209.0K | 39,727 | — | ↗ |
| 2022-06-10 | Walsh Jeffrey T. | Director | A-Award | A | Stock Option (Right to buy) | 39,727 | 0.00 | — | 39,727 | — | ↗ |
| 2022-06-10 | Stehman-Breen Catherine | Director | A-Award | A | Stock Option (Right to buy) | 39,727 | 0.00 | — | 39,727 | — | ↗ |
| 2022-06-10 | Srivastava Deepak | Director | A-Award | A | Stock Option (Right to buy) | 39,727 | 0.00 | — | 39,727 | — | ↗ |
| 2022-06-10 | Lee June | Director | A-Award | A | Stock Option (Right to buy) | 39,727 | 0.00 | — | 39,727 | — | ↗ |
| 2022-06-10 | GOEDDEL DAVID V | Director | A-Award | A | Stock Option (Right to buy) | 39,727 | 0.00 | — | 39,727 | — | ↗ |
| 2022-06-10 | Casdin Eli | Director | A-Award | A | Stock Option (Right to buy) | 39,727 | 0.00 | — | 39,727 | — | ↗ |
| 2022-06-10 | CHEN JIN-LONG | Director | A-Award | A | Stock Option (Right to buy) | 39,727 | 5.26 | 209.0K | 39,727 | — | ↗ |
| 2022-04-26 | Hoey Timothy | Officer | S-Sale | D | Common Stock | 1,353 | 10.13 | 13.7K | 198,646 | — | ↗ |
| 2022-03-15 | Saito Chihiro | Officer | — | D | Stock Option (Right to Buy) | 7,500 | 15.19 | 113.9K | 0 | — | ↗ |
| 2022-02-15 | Tingley Whittemore | Officer | A-Award | A | Stock Option (Right to buy) | 141,000 | 15.19 | 2.14M | 141,000 | — | ↗ |
| 2022-02-15 | PATTERSON LEONE D | Officer | A-Award | A | Stock Option (Right to buy) | 66,000 | 15.19 | 1.00M | 66,000 | — | ↗ |
| 2022-02-15 | Hoey Timothy | Officer | A-Award | A | Stock Option (Right to buy) | 168,000 | 15.19 | 2.55M | 168,000 | — | ↗ |
| 2022-02-15 | Ali Faraz | Director / Officer | A-Award | A | Stock Option (Right to buy) | 401,390 | 15.19 | 6.10M | 401,390 | — | ↗ |
| 2021-12-22 | Parschauer Karah Herdman | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-11-19 | Lee June | Director | A-Award | A | Stock Option (Right to Buy) | 18,937 | 21.65 | 410.0K | 18,937 | — | ↗ |
| 2021-08-03 | Kang JeenJoo | Director | C-Conversion | A | Common Stock | 12,500 | 0.00 | — | 25,000 | — | ↗ |
| 2021-08-03 | GOEDDEL DAVID V | Director / 10% Owner | C-Conversion | D | Series B Preferred Stock | 533,781 | 0.00 | — | 0 | — | ↗ |
| 2021-08-03 | Casdin Partners Master Fund, L.P. | 10% Owner | C-Conversion | D | Series B Preferred Stock | 2,012,880 | 0.00 | — | 0 | — | ↗ |
| 2021-08-03 | Casdin Eli | Director / 10% Owner | P-Purchase | A | Common Stock | 850,000 | 15.00 | 12.75M | 3,224,849 | — | ↗ |
| 2021-08-03 | COLUMN GROUP III GP, LP | 10% Owner | C-Conversion | D | Series A Preferred Stock | 4,209,755 | 0.00 | — | 0 | — | ↗ |
| 2021-07-29 | Williams R Sanders | Director | — | D | Common Stock | 0 | 0.00 | — | 29,999 | — | ↗ |
| 2021-07-29 | Walsh Jeffrey T. | Director | — | D | Stock Option (Right to Buy) | 10,000 | 9.36 | 93.6K | 0 | — | ↗ |
| 2021-07-29 | Tingley Whittemore | Officer | — | D | Stock Option (Right to Buy) | 25,000 | 5.64 | 141.0K | 0 | — | ↗ |
| 2021-07-29 | Stehman-Breen Catherine | Director | — | D | Stock Option (Right to Buy) | 21,875 | 2.70 | 59.1K | 0 | — | ↗ |
| 2021-07-29 | Srivastava Deepak | Director | — | D | Common Stock | 0 | 0.00 | — | 191,666 | — | ↗ |
| 2021-07-29 | PATTERSON LEONE D | Officer | — | D | Stock Option (Right to Buy) | 354,166 | 10.56 | 3.74M | 0 | — | ↗ |
| 2021-07-29 | Kang JeenJoo | Director | — | D | Series A Preferred Stock | 12,500 | 0.00 | — | 0 | — | ↗ |
| 2021-07-29 | Hoey Timothy | Officer | — | D | Common Stock | 0 | 0.00 | — | 199,999 | — | ↗ |
| 2021-07-29 | GOEDDEL DAVID V | Director / 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 25,438 | — | ↗ |
| 2021-07-29 | Casdin Partners Master Fund, L.P. | 10% Owner | — | I | Series C Preferred Stock | 361,969 | 0.00 | — | 0 | — | ↗ |
| 2021-07-29 | Casdin Eli | Director / 10% Owner | — | I | Series B Preferred Stock | 2,012,880 | 0.00 | — | 0 | — | ↗ |
| 2021-07-29 | COLUMN GROUP III GP, LP | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 28,728 | — | ↗ |
| 2021-07-29 | CHEN JIN-LONG | Director | — | D | Common Stock | 0 | 0.00 | — | 25,000 | — | ↗ |
| 2021-07-29 | Ali Faraz | Director / Officer | — | D | Stock Option (Right to buy) | 425,000 | 0.66 | 280.5K | 0 | — | ↗ |
| 2021-03-10 | Higa Tomohiro | Officer | — | — | Stock Option (Right to Buy) | 14,531 | 2.70 | 39.2K | 0 | D | ↗ |
Executive team
Top executives
Shares Outstanding
166.60M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Faraz Ali, M.B.A. Chief Executive Officer | 664.2K | — | 141.9K | 755.5K | 319.3K | 516.00 | 1.88M | 47.70% | ↗ |
| 2 | 2025 | Whittemore (Whit) Tingley, M.D., Ph.D. Chief Medical Officer | 521.2K | — | 86.7K | 385.1K | 180.1K | 1.5K | 1.17M | 40.17% | ↗ |
| 3 | 2024 | Faraz Ali, M.B.A. | 636.2K | — | 443.7K | 2.05M | 153.5K | 636.00 | 3.28M | 75.92% | ↗ |
| 4 | 2024 | Faraz Ali, M.B.A. Chief Executive Officer | 636.2K | — | 443.7K | 2.05M | 153.5K | 636.00 | 3.28M | 75.92% | ↗ |
| 5 | 2024 | Whittemore (Whit) Tingley, M.D., Ph.D. Chief Medical Officer | 504.9K | — | 182.7K | 871.9K | 100.0K | 1.6K | 1.66M | 63.49% | ↗ |
| 6 | 2024 | Whittemore (Whit) Tingley, M.D., Ph.D. | 504.9K | — | 182.7K | 871.9K | 100.0K | 1.6K | 1.66M | 63.49% | ↗ |
| 7 | 2024 | Leone D. Patterson, M.B.A. | 349.5K | — | 182.7K | 831.3K | — | 1.4K | 1.36M | 74.29% | ↗ |
| 8 | 2023 | Faraz Ali, M.B.A. | 593.8K | — | 382.5K | 1.62M | 293.9K | 2.3K | 2.89M | 69.20% | ↗ |
| 9 | 2023 | Whittemore (Whit) Tingley, M.D., Ph.D. | 475.0K | — | 244.8K | 491.2K | 167.0K | 3.8K | 1.38M | 53.27% | ↗ |
| 10 | 2023 | Leone Patterson. | 455.0K | — | 198.9K | 455.3K | 160.0K | 4.4K | 1.27M | 51.37% | ↗ |
| 11 | 2023 | Leone D. Patterson, M.B.A. | 455.0K | — | 198.9K | 455.3K | 160.0K | 4.4K | 1.27M | 51.37% | ↗ |
| 12 | 2022 | Faraz Ali, M.B.A. | 571.5K | — | — | 4.75M | 242.7K | 2.2K | 5.57M | 85.34% | ↗ |
| 13 | 2022 | Timothy Hoey, Ph.D. | 420.5K | — | — | 1.99M | 147.0K | 5.5K | 2.56M | 77.63% | ↗ |
| 14 | 2022 | Whittemore (Whit) Tingley, M.D., Ph.D. | 455.6K | — | — | 1.67M | 162.0K | 4.4K | 2.29M | 72.85% | ↗ |
| 15 | 2022 | Leone Patterson. | 445.6K | — | — | 781.2K | 133.5K | 4.9K | 1.37M | 57.22% | ↗ |
| 16 | 2021 | Faraz Ali, M.B.A. | 493.8K | — | — | 4.26M | 216.1K | 896.00 | 4.97M | 85.70% | ↗ |
| 17 | 2021 | Leone D. Patterson, M.B.A. | 216.5K | — | — | 3.41M | 75.6K | 1.9K | 3.71M | 92.07% | ↗ |
| 18 | 2021 | Whittemore (Whit) Tingley, M.D., Ph.D. | 402.9K | — | — | 1.15M | 146.0K | 2.2K | 1.70M | 67.53% | ↗ |
| 19 | 2021 | Timothy Hoey, Ph.D. | 387.1K | — | — | 94.0K | 134.0K | 4.2K | 619.3K | 15.18% | ↗ |
| 20 | 2020 | Faraz Ali, M.B.A. | 425.0K | 126.5K | — | 197.5K | — | 1.3K | 750.3K | 26.32% | ↗ |
| 21 | 2020 | Whittemore (Whit) Tingley, M.D., Ph.D. | 371.0K | 95.0K | — | — | — | 1.5K | 467.5K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Faraz Ali | Chief Executive Officer, Interim Principal Financial Officer & Director | 984.0K | male |
| Whittemore G. Tingley | Chief Medical Officer | 702.8K | — |
| Deepak Srivastava | Scientific Founder, Chairman of Scientific Advisory Board & Director | 90.5K | — |
| Benoit G. Bruneau | Scientific Founder | — | — |
| Saptarsi Haldar | Scientific Founder | — | — |
| Sheng Ding | Scientific Founder | — | — |
| Tomohiro Higa | Senior Vice President of Finance & Interim Principal Accounting Officer | — | male |
| Kee-Hong Kim | Chief Technology Officer | — | — |
| Bruce R. Conklin | Scientific Founder | — | — |
| Eric N. Olson | Scientific Founder & Member of Scientific Advisory Board | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TNYA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
